MGTX Meiragtx Holdings Plc

MeiraGTx Holdings PLC is a clinical stage gene therapy company. Its pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, the company generates a majority of its revenue from the United Kingdom.

$15.28  +0.27 (1.80%)
As of 06/18/2021 15:59:35 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Cayman Islands
IPO date:  06/08/2018
Outstanding shares:  44,282,073
Average volume:  101,971
Market cap:   $664,673,916
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G59665102
ISIN:        KYG596651029
Sedol:      BFYQFJ2
Valuation   (See tab for details)
PE ratio:   -10.32
PB ratio:   3.08
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy